Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9642
Peer-review started: July 25, 2016
First decision: September 12, 2016
Revised: September 24, 2016
Accepted: October 19, 2016
Article in press: October 19, 2016
Published online: November 21, 2016
To perform meta-analysis of the use of Endocuff during average risk screening colonoscopy.
Scopus, Cochrane databases, MEDLINE/PubMed, and CINAHL were searched in April 2016. Abstracts from Digestive Disease Week, United European Gastroenterology, and the American College of Gastroenterology meeting were also searched from 2004-2015. Studies comparing EC-assisted colonoscopy (EAC) to standard colonoscopy, for any indication, were included in the analysis. The analysis was conducted by using the Mantel-Haenszel or DerSimonian and Laird models with the odds ratio (OR) to assess adenoma detection, cecal intubation rate, and complications performed.
Nine studies (n = 5624 patients) were included in the analysis. Compared to standard colonoscopy, procedures performed with EC had higher frequencies for adenoma (OR = 1.49, 95%CI: 1.23-1.80; P = 0.03), and sessile serrated adenomas detection (OR = 2.34 95%CI: 1.63-3.36; P < 0.001). There was no significant difference in cecal intubation rates between the EAC group and standard colonoscopy (OR = 1.26, 95%CI: 0.70-2.27, I2 = 0%; P = 0.44). EAC was associated with a higher risk of complications, most commonly being superficial mucosal injury without higher frequency for perforation.
The use of an EC on colonoscopy appears to improve pre-cancerous polyp detection without any difference in cecal intubation rates compared to standard colonoscopy.
Core tip: Our meta-analysis of more than 5000 patients demonstrates that when compared to traditional colonoscopy, the use of an Endocuff device improves adenoma detection rates without any adverse effect on procedural efficiency or increased risk of significant adverse events.